Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BAZAN, Viviana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.793
EU - Europa 6.808
AS - Asia 1.467
SA - Sud America 20
AF - Africa 15
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 12
Totale 24.130
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.760
IT - Italia 1.776
FI - Finlandia 1.471
DE - Germania 1.179
CN - Cina 1.057
UA - Ucraina 704
GB - Regno Unito 380
IE - Irlanda 340
SE - Svezia 279
RU - Federazione Russa 202
BE - Belgio 134
RO - Romania 108
IN - India 93
FR - Francia 91
KR - Corea 82
IR - Iran 54
TR - Turchia 35
NL - Olanda 29
HK - Hong Kong 23
CA - Canada 22
AT - Austria 19
ES - Italia 18
JP - Giappone 16
CH - Svizzera 14
AU - Australia 13
PK - Pakistan 13
TW - Taiwan 13
EU - Europa 12
PL - Polonia 11
MX - Messico 10
GR - Grecia 9
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
DK - Danimarca 7
EG - Egitto 7
ID - Indonesia 7
SG - Singapore 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
IL - Israele 6
LB - Libano 6
BR - Brasile 5
KZ - Kazakistan 5
VN - Vietnam 5
AR - Argentina 4
CL - Cile 4
TH - Thailandia 4
ZA - Sudafrica 4
CY - Cipro 3
EE - Estonia 3
HU - Ungheria 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
PE - Perù 3
PH - Filippine 3
SA - Arabia Saudita 3
AL - Albania 2
BD - Bangladesh 2
BY - Bielorussia 2
CO - Colombia 2
KH - Cambogia 2
LY - Libia 2
MK - Macedonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
EC - Ecuador 1
GE - Georgia 1
HR - Croazia 1
IM - Isola di Man 1
IQ - Iraq 1
KW - Kuwait 1
LK - Sri Lanka 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PY - Paraguay 1
RS - Serbia 1
UG - Uganda 1
Totale 24.130
Salva come PNG Salva come JPEG
Città #
Fairfield 2.440
Ashburn 1.521
Chandler 1.393
Woodbridge 1.349
Houston 1.108
Wilmington 1.096
Ann Arbor 1.055
Seattle 951
Cambridge 790
Palermo 512
Jacksonville 373
Dublin 333
Medford 333
Nanjing 250
Des Moines 242
Princeton 215
Altamura 206
New York 203
Lawrence 175
San Diego 163
Brussels 133
Boardman 121
Dearborn 120
Tulsa 110
Ludwigshafen am Rhein 105
Beijing 97
Shenyang 79
Jinan 76
Seongnam 70
Nanchang 65
Milan 61
Venice 61
Hebei 60
London 56
Bremen 55
Kumar 55
Changsha 54
Helsinki 52
Tianjin 51
Jiaxing 45
Phoenix 45
Tehran 37
Los Angeles 36
Ningbo 36
Saint Petersburg 36
Falls Church 35
San Mateo 34
Guangzhou 33
San Paolo di Civitate 32
Auburn Hills 30
Izmir 29
Verona 28
Redwood City 25
Rome 25
Zhengzhou 25
Munich 23
Kilburn 22
Norwalk 22
Hangzhou 20
Taiyuan 20
Chicago 18
Pune 18
Kunming 17
Washington 17
Taizhou 16
Fuzhou 14
Haikou 14
Orange 14
Hanover 13
Moscow 13
Lanzhou 12
Tappahannock 12
Lancaster 11
Atlanta 10
Milazzo 10
Central 9
Edinburgh 9
Frankfurt am Main 8
Hefei 8
Mazara del Vallo 8
Melfi 8
Padova 8
Toronto 8
Aversa 7
Central District 7
Madrid 7
Nürnberg 7
San Francisco 7
Shanghai 7
Tokyo 7
Vienna 7
Amsterdam 6
Groningen 6
Hong Kong 6
Ludwigshafen 6
Napoli 6
Ottawa 6
Stockholm 6
Taipei 6
Bologna 5
Totale 17.211
Salva come PNG Salva come JPEG
Nome #
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment 276
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 260
EGFR inhibition in NSCLC: New findings…. and opened questions? 247
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. 215
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 210
Dietary restriction: could it be considered as speed bump on tumor progression road? 205
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 198
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 196
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 193
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 191
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients 191
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 189
Founder mutations in BRCA1 and BRCA2 genes 188
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 186
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 185
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 183
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 179
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 177
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 177
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 174
Apoptosis: a relevant tool for anticancer therapy. 173
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 172
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 172
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. 172
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 171
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 171
A headlight on liquid biopsies: a challenging tool for breast cancer management 168
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 166
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 165
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 164
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 163
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 161
Anti-endothelin drugs in solid tumors 161
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 160
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 159
Nintedanib in NSCLC: Evidence to date and place in therapy 159
Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy 158
Monoclonal antibodies in gastrointestinal cancers 158
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 157
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. 156
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 156
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 156
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 153
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 153
Breast cancer genome-wide association studies: there is strength in numbers 153
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. 152
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 152
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 152
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 151
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 151
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 150
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations 150
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 149
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 147
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status 147
Laser Pressure Catapulting (LPC): Optimization LPC-System and Genotyping of Colorectal Carcinomas 146
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors 146
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 146
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma 145
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. 144
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 144
The role of Aurora-A inhibitors in cancer therapy. 143
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability. 143
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 143
Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. 143
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 143
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 143
Ductal lavage: a way of carefully tracing the breast-secreting duct 142
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 142
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer. 141
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation? 141
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 141
Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family. 138
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 138
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 138
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 137
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 136
TP53, H-K-RAS, P16INK4A GENE MOLECULAR ANALYSIS IN SALIVARY GLAND TUMORS 136
miR-20b Modulates VEGF Expression by Targeting HIF-1a and STAT3 in MCF-7 Breast Cancer Cells 136
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario 136
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. 135
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis 135
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 135
P16 ink4A, p53 alterations and S phase fraction are predictive of clinical outcome in laryngeal squamous cell carcinoma. 132
VUS variants in BRCA genes of hereditary breast/ovarian cancer 132
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 132
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 132
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions 132
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome 131
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 131
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer 130
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? 130
Hereditary ovarian cancer 129
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab 129
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) 128
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma 127
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) 126
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. 126
Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells. 125
Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy? 124
Totale 15.710
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.071
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019970 0 0 0 0 0 0 0 0 0 0 489 481
2019/20206.257 595 283 391 842 676 735 609 426 550 378 569 203
2020/20213.554 199 249 194 319 421 154 263 254 420 392 363 326
2021/20223.121 217 680 89 127 158 122 200 146 290 376 259 457
2022/20233.972 432 755 97 478 434 594 218 289 413 30 173 59
2023/20241.747 85 245 141 164 128 411 239 241 21 71 1 0
Totale 25.200